The Path to Growth in Castrate-Resistant Prostate Cancer Market

added blog Other

2025-09-17 13:20:00 - Translate

The global castrate-resistant prostate cancer (CRPC) market is experiencing steady growth, driven by the rising prevalence of prostate cancer, the increasing adoption of targeted therapies, and advancements in oncology research. Valued at USD 12.92 billion in 2024, the market is projected to reach USD 29.79 billion by 2034, expanding at a compound annual growth rate...

0 Comments 0 Shares 24 Views 0 Reviews